Unlocking Wnt Targeting Without the Toxicity

Almost all colorectal cancers are driven by the Wnt signaling pathway. However, Wnt inhibition strategies have not been successful. A major barrier has been on-target toxicity, as Wnt signaling is vital for healthy tissues. Adeno overcomes this challenge with the first therapy that selectively eliminates Wnt-driven tumors wtihout toxicity.